Cargando…

Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin

Antibody responses to influenza virus hemagglutinin provide protection against infection and are well studied. Less is known about the human antibody responses to the second surface glycoprotein, neuraminidase. Here, we assessed human antibody reactivity to a panel of N1, N2, and influenza B virus n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajendran, Madhusudan, Nachbagauer, Raffael, Ermler, Megan E., Bunduc, Paul, Amanat, Fatima, Izikson, Ruvim, Cox, Manon, Palese, Peter, Eichelberger, Maryna, Krammer, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362038/ https://www.ncbi.nlm.nih.gov/pubmed/28325769 http://dx.doi.org/10.1128/mBio.02281-16

Ejemplares similares

Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans
por: Nachbagauer, Raffael, et al.
Publicado: (2016)

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
por: Stadlbauer, Daniel, et al.
Publicado: (2017)

An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations
por: Rajendran, Madhusudan, et al.
Publicado: (2018)

Vaccination with Adjuvanted Recombinant Neuraminidase Induces Broad Heterologous, but Not Heterosubtypic, Cross-Protection against Influenza Virus Infection in Mice
por: Wohlbold, Teddy John, et al.
Publicado: (2015)

Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model
por: Jacobsen, Henning, et al.
Publicado: (2017)

Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model
por: Stadlbauer, Daniel, et al.
Publicado: (2018)

The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination
por: Rajendran, Madhusudan, et al.
Publicado: (2021)

Monoclonal antibodies targeting the influenza virus N6 neuraminidase
por: Strohmeier, Shirin, et al.
Publicado: (2022)

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay
por: Gao, Jin, et al.
Publicado: (2016)

Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding
por: Gentles, Lauren E., et al.
Publicado: (2020)

Label‐free mass spectrometry‐based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines
por: Getie‐Kebtie, Melkamu, et al.
Publicado: (2012)

Neuraminidase activity provides a practical read-out for a high throughput influenza antiviral screening assay
por: Eichelberger, Maryna C, et al.
Publicado: (2008)

A miniaturized assay for influenza neuraminidase‐inhibiting antibodies utilizing reverse genetics‐derived antigens
por: Sandbulte, Matthew R., et al.
Publicado: (2009)

A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies
por: Nachbagauer, Raffael, et al.
Publicado: (2017)

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes
por: Wohlbold, Teddy John, et al.
Publicado: (2017)

NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
por: Krammer, Florian, et al.
Publicado: (2018)

A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice
por: Strohmeier, Shirin, et al.
Publicado: (2022)

A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains
por: Broecker, Felix, et al.
Publicado: (2019)

A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory Study
por: Nachbagauer, Raffael, et al.
Publicado: (2018)

Original sins /
por: Alther, Lisa

Safety of Recombinant Influenza Vaccine Compared to Inactivated Influenza Vaccine in Adults: An Observational Study
por: Hansen, John, et al.
Publicado: (2020)

Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults
por: Meade, Philip, et al.
Publicado: (2020)

A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice
por: Nachbagauer, Raffael, et al.
Publicado: (2016)

Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model
por: Liu, Wen-Chun, et al.
Publicado: (2019)

Genetics of Original Sin
por: Schwendinger-Schreck, Jamie
Publicado: (2011)

Use of lentiviral pseudotypes as an alternative to reassortant or Triton X‐100‐treated wild‐type Influenza viruses in the neuraminidase inhibition enzyme‐linked lectin assay
por: Biuso, Fabrizio, et al.
Publicado: (2019)

Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase
por: Meseda, Clement A., et al.
Publicado: (2018)

A cross-reactive mouse monoclonal antibody against rhinovirus mediates phagocytosis in vitro
por: Behzadi, Mohammad Amin, et al.
Publicado: (2020)

Novel correlates of protection against pandemic H1N1 influenza A virus infection
por: Ng, Sophia, et al.
Publicado: (2019)

The Wages of Original Antigenic Sin
por: Morens, David M., et al.
Publicado: (2010)

Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers
por: Wan, Hongquan, et al.
Publicado: (2015)

Cryo-electron Microscopy Structures of Chimeric Hemagglutinin Displayed on a Universal Influenza Vaccine Candidate
por: Tran, Erin E. H., et al.
Publicado: (2016)

Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model
por: Liu, Wen-Chun, et al.
Publicado: (2021)

A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model
por: Strohmeier, Shirin, et al.
Publicado: (2021)

Development and characterization of a quantitative ELISA to detect anti-SARS-CoV-2 spike antibodies
por: Żak, Magdalena M., et al.
Publicado: (2021)

Yet it Endures: The Persistence of Original Sin
por: Eichengreen, Barry, et al.
Publicado: (2022)

Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults
por: Maier, Hannah E, et al.
Publicado: (2020)

Antigen modifications improve nucleoside-modified mRNA-based influenza virus vaccines in mice
por: Freyn, Alec W., et al.
Publicado: (2021)

Peter's Paradigm and Pandemic Preparedness
por: Eichelberger, Maryna C.
Publicado: (2020)

SARS-CoV-2 Vaccines: Status Report
por: Amanat, Fatima, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_sg9ivda3l75d94ucuef5afmc1e